Range
42.84 - 45.79
Vol / Avg.
524.3K/1.8M
Div / Yield
-
52 Wk
27.5 - 73
Mkt Cap
4.2B
Payout Ratio
-
Open
44.08
P/E
-
EPS
-2.28
Shares
97.4M
Outstanding
97.4M
Total Float
70.6M
Benzinga - Sep 10, 2021, 10:40AM
load more
Sector: Health Care.Industry: Biotechnology
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-02-24
REV
Q3 2021Est.ActualSurprise
EPS-1.750-1.570 0.1800
REV7.220M5.650M-1.570M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Apellis Pharmaceuticals Questions & Anwsers

Q

How do I buy Apellis Pharmaceuticals (APLS) stock?

A

You can purchase shares of Apellis Pharmaceuticals (NASDAQ: APLS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Apellis Pharmaceuticals's (APLS) competitors?

Q

What is the target price for Apellis Pharmaceuticals (APLS) stock?

A

The latest price target for Apellis Pharmaceuticals (NASDAQ: APLS) was reported by Citigroup on November 24, 2021. The analyst firm set a price target for 72.00 expecting APLS to rise to within 12 months (a possible 65.37% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Apellis Pharmaceuticals (APLS)?

A

The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $43.54 last updated Fri Nov 26 2021 18:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Apellis Pharmaceuticals (APLS) pay a dividend?

A

There are no upcoming dividends for Apellis Pharmaceuticals.

Q

When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?

A

Apellis Pharmaceuticals’s $Q4 earnings are confirmed for after-market on February 24, 2022.

Q

Is Apellis Pharmaceuticals (APLS) going to split?

A

There is no upcoming split for Apellis Pharmaceuticals.

Q

What sector and industry does Apellis Pharmaceuticals (APLS) operate in?

A

Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.